Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 120(Pt A): 641-649, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30171942

RESUMO

Astragalus polysaccharides (APS) were treated with different gamma irradiation doses (10, 25, 50, 100 and 150 kGy) to investigate the effects of gamma radiation processing on structure, physicochemical and immunomodulatory properties. The results revealed both the number-average and weight-average molecular weight of APS significantly decreased with increasing irradiation dose, whereas the solubility was increased after irradiation. A decrease in the apparent viscosity, as well as an increase in amount of small fragments of APS granules was also observed with increasing irradiation dose. FT-IR spectra indicated that gamma irradiation introduced no significant changes into the functional group status of APS. High irradiation dose (>50 kGy) caused a significant increase of yellowness and a slightly decrease of thermal stability of APS. Further, the immunomodulatory activity of irradiated APS was evaluated on Caco2 cells. APS irradiated at dose of 25 kGy exhibited the highest ability to induce nitric oxide production and up-regulate the mRNA expression of inflammatory cytokines, occludin, zonula occludens protein-1 (ZO-1) and toll-like receptor 4 (TLR4), as well as the protein expression of ZO-1 and TLR4. These findings indicate that gamma irradiation modification with a proper dose enhance immunomodulatory activity of APS by improving physicochemical properties without changing the functional groups.


Assuntos
Astrágalo/química , Raios gama , Regulação da Expressão Gênica/efeitos dos fármacos , Fatores Imunológicos/efeitos da radiação , Polissacarídeos/efeitos da radiação , Células CACO-2 , Sobrevivência Celular/efeitos dos fármacos , Cor , Citocinas/agonistas , Citocinas/genética , Citocinas/imunologia , Relação Dose-Resposta Imunológica , Relação Dose-Resposta à Radiação , Humanos , Fatores Imunológicos/isolamento & purificação , Fatores Imunológicos/farmacologia , Peso Molecular , Óxido Nítrico/agonistas , Óxido Nítrico/biossíntese , Óxido Nítrico/imunologia , Ocludina/agonistas , Ocludina/genética , Ocludina/imunologia , Polissacarídeos/isolamento & purificação , Polissacarídeos/farmacologia , Solubilidade/efeitos da radiação , Receptor 4 Toll-Like/agonistas , Receptor 4 Toll-Like/genética , Receptor 4 Toll-Like/imunologia , Viscosidade/efeitos da radiação , Proteína da Zônula de Oclusão-1/agonistas , Proteína da Zônula de Oclusão-1/genética , Proteína da Zônula de Oclusão-1/imunologia
2.
Biochem Pharmacol ; 120: 63-71, 2016 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-27641813

RESUMO

Despite pharmacological treatment, bronchial hyperresponsiveness continues to deteriorate as airway remodelling persists in airway inflammation. Previous studies have demonstrated that the phytocannabinoid Δ9-tetrahydrocannabinol (THC) reverses bronchoconstriction with an anti-inflammatory action. The aim of this study was to investigate the effects of THC on bronchial epithelial cell permeability after exposure to the pro-inflammatory cytokine, TNFα. Calu-3 bronchial epithelial cells were cultured at air-liquid interface. Changes in epithelial permeability were measured using Transepithelial Electrical Resistance (TEER), then confirmed with a paracellular permeability assay and expression of tight junction proteins by Western blotting. Treatment with THC prevented the TNFα-induced decrease in TEER and increase in paracellular permeability. Cannabinoid CB1 and CB2 receptor-like immunoreactivity was found in Calu-3 cells. Subsequent experiments revealed that pharmacological blockade of CB2, but not CB1 receptor inhibited the THC effect. Selective stimulation of CB2 receptors displayed a similar effect to that of THC. TNFα decreased expression of the tight junction proteins occludin and ZO-1, which was prevented by pre-incubation with THC. These data indicate that THC prevents cytokine-induced increase in airway epithelial permeability through CB2 receptor activation. This highlights that THC, or other cannabinoid receptor ligands, could be beneficial in the prevention of inflammation-induced changes in airway epithelial cell permeability, an important feature of airways diseases.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Brônquios/efeitos dos fármacos , Agonistas de Receptores de Canabinoides/farmacologia , Dronabinol/farmacologia , Alucinógenos/farmacologia , Receptor CB2 de Canabinoide/agonistas , Mucosa Respiratória/efeitos dos fármacos , Algoritmos , Anti-Inflamatórios não Esteroides/metabolismo , Brônquios/imunologia , Brônquios/metabolismo , Agonistas de Receptores de Canabinoides/metabolismo , Antagonistas de Receptores de Canabinoides/farmacologia , Linhagem Celular Tumoral , Permeabilidade da Membrana Celular/efeitos dos fármacos , Dronabinol/metabolismo , Impedância Elétrica , Alucinógenos/metabolismo , Humanos , Interleucina-1beta/antagonistas & inibidores , Interleucina-1beta/metabolismo , Cinética , Ligantes , Ocludina/agonistas , Ocludina/antagonistas & inibidores , Ocludina/metabolismo , Permeabilidade/efeitos dos fármacos , Receptor CB2 de Canabinoide/antagonistas & inibidores , Receptor CB2 de Canabinoide/metabolismo , Mucosa Respiratória/imunologia , Mucosa Respiratória/metabolismo , Proteínas de Junções Íntimas/agonistas , Proteínas de Junções Íntimas/antagonistas & inibidores , Proteínas de Junções Íntimas/metabolismo , Junções Íntimas/efeitos dos fármacos , Junções Íntimas/metabolismo , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Fator de Necrose Tumoral alfa/metabolismo , Proteína da Zônula de Oclusão-1/agonistas , Proteína da Zônula de Oclusão-1/antagonistas & inibidores , Proteína da Zônula de Oclusão-1/metabolismo
3.
Nutr Cancer ; 68(7): 1225-33, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27564600

RESUMO

All-trans-retinoic acid (ATRA) inhibits the invasive and metastatic potentials of various cancer cells. However, the underlying mechanism is unclear. Here, we demonstrate that ATRA inhibited colorectal cancer cells RKO (human colon adenocarcinoma cell) migration by downregulating cell movement and increasing cell adhesion. ATRA inhibited the expression and activation of myosin light chain kinase (MLCK) in RKO cells, while the expression level of MLC phosphatase (MLCP) had no change in RKO cells treated with or without ATRA. The expression and activity of MLC was also inhibited in RKO cells exposed to ATRA. Intriguingly, ATRA increased the expression of occludin messenger RNA (mRNA) and protein and its localization on cell membrane. However, ATRA did not change the expression of zonula occludens 1 (ZO-1), but increased the accumulation of ZO-1 on RKO cells membrane. ML-7, an inhibitor of MLCK, significantly inhibited RKO cell migration. Furthermore, knockdown of endogenous MLCK expression inhibited RKO migration. Mechanistically, we showed that MAPK-specific inhibitor PD98059 enhanced the inhibitory effect of ATRA on RKO migration. In contrast, phorbol 12-myristate 13-acetate (PMA) attenuated the effects of ATRA in RKO cells. Moreover, knocking down endogenous extracellular signal-regulated kinase (ERK) expression inhibited MLCK expression in the RKO cells. In conclusion, ATRA inhibits RKO migration by reducing MLCK expression via extracellular signal-regulated kinase 1/Mitogen-activated protein kinase (ERK1/MAPK) signaling pathway.


Assuntos
Antineoplásicos/farmacologia , Neoplasias Colorretais/tratamento farmacológico , Regulação para Baixo/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Quinase de Cadeia Leve de Miosina/antagonistas & inibidores , Tretinoína/farmacologia , Carcinógenos/farmacologia , Linhagem Celular Tumoral , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Membrana Celular/patologia , Movimento Celular/efeitos dos fármacos , Neoplasias Colorretais/metabolismo , Neoplasias Colorretais/patologia , Ativação Enzimática/efeitos dos fármacos , Humanos , Cinética , Quinase de Cadeia Leve de Miosina/genética , Quinase de Cadeia Leve de Miosina/metabolismo , Proteínas de Neoplasias/antagonistas & inibidores , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Ocludina/agonistas , Ocludina/antagonistas & inibidores , Ocludina/genética , Ocludina/metabolismo , Inibidores de Proteínas Quinases/farmacologia , Interferência de RNA , Junções Íntimas/efeitos dos fármacos , Junções Íntimas/metabolismo , Junções Íntimas/patologia , Proteína da Zônula de Oclusão-1/agonistas , Proteína da Zônula de Oclusão-1/antagonistas & inibidores , Proteína da Zônula de Oclusão-1/genética , Proteína da Zônula de Oclusão-1/metabolismo
4.
Toxicol Sci ; 148(1): 311-29, 2015 11.
Artigo em Inglês | MEDLINE | ID: mdl-26424772

RESUMO

Cadmium (Cd) causes male infertility. There is the need to identify safe treatments counteracting this toxicity. Flavocoxid is a flavonoid that induces a balanced inhibition of cyclooxygenase (COX)-1 and COX-2 peroxidase moieties and of 5-lipoxygenase (LOX) and has efficacy in the male genitourinary system. We investigated flavocoxid effects on Cd-induced testicular toxicity in mice. Swiss mice were divided into 4 groups: 2 control groups received 0.9% NaCl (vehicle; 1 ml/kg/day) or flavocoxid (20 mg/kg/day ip); 2 groups were challenged with cadmium chloride (CdCl2; 2 mg/kg/day ip) and administered with vehicle or flavocoxid. The treatment lasted for 1 or 2 weeks. The testes were processed for biochemical and morphological studies. CdCl2 increased phosphorylated extracellular signal-regulated kinase (p-ERK) 1/2, tumor necrosis factor (TNF)-α, COX-2, 5-LOX, malondialdehyde (MDA), B-cell-lymphoma (Bcl)-2-associated X protein (Bax), follicle-stimulating hormone (FSH), luteinizing hormone (LH), transforming growth factor (TGF) -ß3, decreased Bcl-2, testosterone, inhibin-B, occludin, N-Cadherin, induced structural damages in the testis and disrupted the blood-testis barrier. Many TUNEL-positive germ cells and changes in claudin-11, occludin, and N-cadherin localization were present. Flavocoxid administration reduced, in a time-dependent way, p-ERK 1/2, TNF-α, COX-2, 5-LOX, MDA, Bax, FSH, LH, TGF-ß3, augmented Bcl-2, testosterone, inhibin B, occludin, N-Cadherin, and improved the structural organization of the testis and the blood-testis barrier. Few TUNEL-positive germ cells were present and a morphological retrieval of the intercellular junctions was observed. In conclusion, flavocoxid has a protective anti-inflammatory, antioxidant, and antiapoptotic function against Cd-induced toxicity in mice testis. We suggest that flavocoxid may play a relevant positive role against environmental levels of Cd, otherwise deleterious to gametogenesis and tubular integrity.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Barreira Hematotesticular/efeitos dos fármacos , Intoxicação por Cádmio/prevenção & controle , Catequina/uso terapêutico , Infertilidade Masculina/prevenção & controle , Túbulos Seminíferos/efeitos dos fármacos , Espermatogênese/efeitos dos fármacos , Animais , Antioxidantes/uso terapêutico , Apoptose/efeitos dos fármacos , Biomarcadores/metabolismo , Barreira Hematotesticular/metabolismo , Barreira Hematotesticular/patologia , Barreira Hematotesticular/ultraestrutura , Caderinas/agonistas , Caderinas/antagonistas & inibidores , Caderinas/metabolismo , Intoxicação por Cádmio/metabolismo , Intoxicação por Cádmio/patologia , Intoxicação por Cádmio/fisiopatologia , Combinação de Medicamentos , Infertilidade Masculina/etiologia , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Camundongos Endogâmicos C57BL , Ocludina/agonistas , Ocludina/antagonistas & inibidores , Ocludina/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Túbulos Seminíferos/metabolismo , Túbulos Seminíferos/patologia , Túbulos Seminíferos/ultraestrutura , Junções Íntimas/efeitos dos fármacos , Junções Íntimas/metabolismo , Junções Íntimas/patologia , Junções Íntimas/ultraestrutura
5.
Biosci Biotechnol Biochem ; 79(1): 130-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25175351

RESUMO

We investigated the effect of theaflavins (TFs) on membrane barrier of Caco-2 cells. For fluorescein-transport experiments, the apparent permeability (Papp) of fluorescein in Caco-2 cells pretreated with 20 µM TFs were significantly decreased compared with that in untreated cells. Although the respective monomeric catechins did not show any Papp reduction, purpurogallin pretreatment resulted in a significant Papp reduction similar to that of TF-3'-O-gallate (TF3'G) pretreatment. This indicates that the benzotropolone moiety may play a crucial role in the Papp reduction or tight junction (TJ)-closing effect induced by TFs. In TF-3'-O-gallate-pretreated Caco-2 cells, fluorescein transport was completely restored by compound C (AMPK inhibitor). In addition, TF3'G significantly increased both the mRNA and protein expression of TJ-related proteins (occludin, claudin-1, and ZO-1) as well as the phosphorylation of AMPK. It was, thus, concluded that TFs could enhance intestinal barrier function by increasing the expression of TJ-related proteins through the activation of AMPK in Caco-2 cells.


Assuntos
Proteínas Quinases Ativadas por AMP/genética , Antioxidantes/farmacologia , Benzocicloeptenos/farmacologia , Biflavonoides/farmacologia , Catequina/farmacologia , Fluoresceína/metabolismo , Ácido Gálico/análogos & derivados , Proteínas Quinases Ativadas por AMP/antagonistas & inibidores , Proteínas Quinases Ativadas por AMP/metabolismo , Células CACO-2 , Permeabilidade da Membrana Celular/efeitos dos fármacos , Claudina-1/agonistas , Claudina-1/genética , Claudina-1/metabolismo , Relação Dose-Resposta a Droga , Ácido Gálico/farmacologia , Regulação da Expressão Gênica , Humanos , Ocludina/agonistas , Ocludina/genética , Ocludina/metabolismo , Inibidores de Proteínas Quinases/farmacologia , RNA Mensageiro/antagonistas & inibidores , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Transdução de Sinais , Relação Estrutura-Atividade , Junções Íntimas/efeitos dos fármacos , Junções Íntimas/metabolismo , Proteína da Zônula de Oclusão-1/agonistas , Proteína da Zônula de Oclusão-1/genética , Proteína da Zônula de Oclusão-1/metabolismo
6.
J Agric Food Chem ; 61(22): 5291-7, 2013 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-23668856

RESUMO

The aim of this study was to determine the protective effect of quercetin, epigallocatechingallate, resveratrol, and rutin against the disruption of epithelial integrity induced by indomethacin in Caco-2 cell monolayers. Indomethacin decreased the transepithelial electrical resistance and increased the permeability of the monolayers to fluorescein-dextran. These alterations were abolished by all the tested polyphenols but rutin, with quercetin being the most efficient. The protective effect of quercetin was associated with its capacity to inhibit the redistribution of ZO-1 protein induced in the tight junction by indomethacin or rotenone, a mitochondrial complex-I inhibitor, and to prevent the decrease of ZO-1 and occludin expression induced by indomethacin. The fact that the antioxidant polyphenols assayed in this study differ in their protective capacity against the epithelial damage induced by indomethacin suggests that this damage is due to the ability of this agent to induce not only oxidative stress but also mitochondrial dysfunction.


Assuntos
Anti-Inflamatórios não Esteroides/antagonistas & inibidores , Antioxidantes/metabolismo , Enterócitos/metabolismo , Alimento Funcional/análise , Indometacina/antagonistas & inibidores , Ocludina/metabolismo , Proteína da Zônula de Oclusão-1/metabolismo , Anti-Inflamatórios não Esteroides/efeitos adversos , Antioxidantes/análise , Células CACO-2 , Catequina/análogos & derivados , Catequina/análise , Catequina/metabolismo , Enterócitos/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Indometacina/efeitos adversos , Ocludina/agonistas , Ocludina/antagonistas & inibidores , Ocludina/genética , Permeabilidade/efeitos dos fármacos , Polifenóis/análise , Polifenóis/metabolismo , Transporte Proteico/efeitos dos fármacos , Quercetina/análise , Quercetina/metabolismo , Resveratrol , Estilbenos/análise , Estilbenos/metabolismo , Junções Íntimas/efeitos dos fármacos , Proteína da Zônula de Oclusão-1/agonistas , Proteína da Zônula de Oclusão-1/antagonistas & inibidores , Proteína da Zônula de Oclusão-1/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA